Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-31

Clinical Trial Update: Efficacy and Safety of Bivalirudin Versus Heparin During Coil Embolization in Patients With Ruptured Intracranial Aneurysms [Phase 3]

View source ↗

Summary

Phase 3 trial comparing bivalirudin to heparin during coil embolization for ruptured intracranial aneurysms; efficacy and safety data are being reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bivalirudin (bivalirudin)
  • Heparin (unfractionated heparin)

Snippet

Sponsor: Changhai Hospital | Conditions: Subarachnoid Hemorrhage, Aneurysmal | Phase 3 | Status: UNKNOWN